FY2019 EPS Estimates for Monsanto Co. (MON) Lifted by Analyst
Monsanto Co. (NYSE:MON) – Equities research analysts at Jefferies Group increased their FY2019 EPS estimates for shares of Monsanto in a research report issued to clients and investors on Thursday. Jefferies Group analyst L. Alexander now expects that the brokerage will post earnings of $6.40 per share for the year, up from their previous estimate of $6.25. Jefferies Group has a “Buy” rating on the stock.
Several other brokerages also recently commented on MON. S&P Equity Research restated a “positive” rating on shares of Monsanto in a research note on Thursday, September 15th. Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $116.55 price target for the company in a research note on Monday, June 27th. Piper Jaffray Cos. reiterated an “overweight” rating and set a $118.00 price target on shares of Monsanto in a research note on Sunday, August 21st. Citigroup Inc. reiterated a “neutral” rating and set a $112.00 price target on shares of Monsanto in a research note on Monday, July 18th. Finally, Goldman Sachs Group Inc. set a $92.00 price target on Monsanto and gave the company a “sell” rating in a research note on Monday, June 27th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $114.65.
Shares of Monsanto (NYSE:MON) traded down 0.140% during trading on Monday, hitting $103.215. The stock had a trading volume of 179,546 shares. The company has a market capitalization of $45.18 billion, a price-to-earnings ratio of 34.543 and a beta of 1.19. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26. The company’s 50 day moving average price is $104.87 and its 200 day moving average price is $101.43.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/10/fy2019-eps-estimates-for-monsanto-co-mon-lifted-by-analyst.html
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the company earned ($0.19) earnings per share.
A number of hedge funds and other institutional investors have recently made changes to their positions in MON. Advisory Services Network LLC raised its position in shares of Monsanto by 688.3% in the third quarter. Advisory Services Network LLC now owns 7,457 shares of the company’s stock valued at $762,000 after buying an additional 6,511 shares during the period. Franklin Street Advisors Inc. NC raised its position in shares of Monsanto by 24.7% in the third quarter. Franklin Street Advisors Inc. NC now owns 62,980 shares of the company’s stock valued at $6,437,000 after buying an additional 12,475 shares during the period. Acropolis Investment Management LLC raised its position in shares of Monsanto by 4.0% in the third quarter. Acropolis Investment Management LLC now owns 3,319 shares of the company’s stock valued at $339,000 after buying an additional 127 shares during the period. Burke & Herbert Bank & Trust Co. raised its position in shares of Monsanto by 5.5% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 2,606 shares of the company’s stock valued at $266,000 after buying an additional 137 shares during the period. Finally, BNP Paribas Arbitrage SA raised its position in shares of Monsanto by 5.2% in the third quarter. BNP Paribas Arbitrage SA now owns 308,850 shares of the company’s stock valued at $31,564,000 after buying an additional 15,128 shares during the period. Institutional investors own 79.02% of the company’s stock.
In related news, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 annualized dividend and a yield of 2.09%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.